Antiproliferative Activity of a New Nitrosyl Iron Complex with Cysteamine in Human Tumor Cells In Vitro
- Authors: Zhukova O.S.1, Smirnova Z.S.1, Chikileva I.O.1, Kiselevskii M.V.1
- 
							Affiliations: 
							- Laboratory of Cell Immunity, Laboratory of Experimental Cheotherapy, N. N. Blokhin Cancer Research Center, Russian Ministry of Health
 
- Issue: Vol 162, No 4 (2017)
- Pages: 583-588
- Section: Translated from Kletochnye Tekhnologii v Biologii i Meditsine (Cell Technologies in Biology and Medicine)
- URL: https://journals.rcsi.science/0007-4888/article/view/238391
- DOI: https://doi.org/10.1007/s10517-017-3663-8
- ID: 238391
Cite item
Abstract
We studied cytotoxic activity of a new NO-releasing tetranitrosyl binuclear iron complex with cysteamine (CysAm) for human tumor cells, the relationship between the expression of O6-methylguanine-DNA methyltransferase (MGMT) and cell sensitivity to CysAm, and apoptosis-inducing capacity of this preparation. It was found that histogenetically different cell lines are characterized by different sensitivity to CysAm, and this parameter correlated with the basal level of MGMT. CysAm induced apoptosis via activation of caspases 3 and 7. These data suggest that CysAm can be considered as a potential antitumor agent, but definitive conclusions can be made after preclinical trials.
About the authors
O. S. Zhukova
Laboratory of Cell Immunity, Laboratory of Experimental Cheotherapy, N. N. Blokhin Cancer Research Center, Russian Ministry of Health
							Author for correspondence.
							Email: msvz@yandex.ru
				                					                																			                												                	Russian Federation, 							Moscow						
Z. S. Smirnova
Laboratory of Cell Immunity, Laboratory of Experimental Cheotherapy, N. N. Blokhin Cancer Research Center, Russian Ministry of Health
														Email: msvz@yandex.ru
				                					                																			                												                	Russian Federation, 							Moscow						
I. O. Chikileva
Laboratory of Cell Immunity, Laboratory of Experimental Cheotherapy, N. N. Blokhin Cancer Research Center, Russian Ministry of Health
														Email: msvz@yandex.ru
				                					                																			                												                	Russian Federation, 							Moscow						
M. V. Kiselevskii
Laboratory of Cell Immunity, Laboratory of Experimental Cheotherapy, N. N. Blokhin Cancer Research Center, Russian Ministry of Health
														Email: msvz@yandex.ru
				                					                																			                												                	Russian Federation, 							Moscow						
Supplementary files
 
				
			 
					 
						 
						 
						 
						 
				 
  
  
  
  
  Email this article
			Email this article  Open Access
		                                Open Access Access granted
						Access granted Subscription Access
		                                		                                        Subscription Access
		                                					